High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors

Acquired coagulation factor inhibitor is a rare coagulation disorder. We herein report a patient with acquired factor V inhibitor showing a decrease in multiple coagulation factor activities. A high titer of factor V inhibitor presumably led to a marked inhibition of factor V activity in the specific factor-deficient plasma used in coagulation factor activity assays based on either an activated partial thromboplastin time (APTT) or prothrombin time (PT) clotting assay, resulting in false low values of the coagulation activity. We re-examined the coagulation factor activity using several dilutions of the patient's plasma and confirmed that the high factor V inhibitor titer had caused an apparent decrease in multiple coagulation factor activities.

[1]  M. Harisinghani,et al.  Aetiology, imaging features, and evolution of spontaneous perirenal haemorrhage. , 2017, Clinical radiology.

[2]  A. Coppola,et al.  Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. , 2015, The Cochrane database of systematic reviews.

[3]  A. Hillarp,et al.  One‐stage vs. chromogenic assays in haemophilia A , 2015, European journal of haematology.

[4]  Kazuaki Yoshimura,et al.  Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics. , 2014, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[5]  Y. Miyakawa,et al.  Successful treatment of severe lung hemorrhage caused by acquired factor V inhibitor with rituximab. , 2014, Internal medicine.

[6]  G. Lippi,et al.  Acquired factor V inhibitors: a systematic review , 2011, Journal of Thrombosis and Thrombolysis.

[7]  P. Kuperan,et al.  Acquired factor V inhibitor , 2009, Thrombosis and Haemostasis.

[8]  M. Koerper,et al.  Factor V deficiency: a concise review , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[9]  N. Ichikawa,et al.  [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors]. , 2008, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[10]  N. Bayani,et al.  High‐titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors , 2002, American journal of hematology.

[11]  A. Somogyi,et al.  Classification of the kinetics of factor VIII inhibitors in haemophilia A: plasma dilution studies are more discriminatory than time‐course studies , 2001, British journal of haematology.

[12]  B. Baron,et al.  Presurgical plasma exchange for severe factor V deficiency , 2001, Journal of clinical apheresis.

[13]  Y. Ogiso,et al.  [A case positive for the inhibitor for coagulation factor V]. , 1999, Rinsho byori. The Japanese journal of clinical pathology.

[14]  L. Hoyer,et al.  Inactivation of factor VIII coagulant activity by two different types of human antibodies. , 1982, Blood.